Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells.
about
Impact of melatonin on immunity: a reviewEffects of Melatonin on Liver Injuries and Diseases.Melatonin Improves mitochondrial function by promoting MT1/SIRT1/PGC-1 alpha-dependent mitochondrial biogenesis in cadmium-induced hepatotoxicity in vitro.Ceramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells.Vitamin D and melatonin protect the cell's viability and ameliorate the CCl4 induced cytotoxicity in HepG2 and Hep3B hepatoma cell linesA review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives.Melatonin potentiates cisplatin-induced apoptosis and cell cycle arrest in human lung adenocarcinoma cells.Growth-inhibitory activity of melatonin on murine foregastric carcinoma cells in vitro and the underlying molecular mechanism.A Comparison of B16 Melanoma Cells and 3T3 Fibroblasts Concerning Cell Viability and ROS Production in the Presence of Melatonin, Tested Over a Wide Range of Concentrations.Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells.Melatonin suppresses tumor progression by reducing angiogenesis stimulated by HIF-1 in a mouse tumor model.Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.Role of CD4+ CD25+ regulatory T cells in melatonin-mediated inhibition of murine gastric cancer cell growth in vivo and in vitro.Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells.Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells.Melatonin improves ultraviolet B-induced oxidative damage and inflammatory conditions in cutaneous tissue of a diurnal Indian palm squirrel Funambulus pennanti.The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells.Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors.Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin.
P2860
Q22255457-98B44591-5396-4D1E-A530-714F8FA4808FQ33624211-752439C7-1A8E-4B97-9950-BCDA9D50ECC7Q34483955-45625499-CDE3-4E41-B58E-A5F11D648E26Q35912091-43C53D4E-3BF2-4C64-83A5-EE1DBDDFDA00Q36237046-B5305C1C-726E-4949-ABA1-BEC04B5C89F8Q38020932-36C9297F-9D5B-4124-9680-115C99D08935Q38920808-C1CDAF47-A3E2-45D5-B7A0-BA3AD2702C83Q39169757-F433659A-74C9-4E92-AB13-EFFC77C66BBDQ39189852-25D15F8C-5279-47D9-8A3D-53EAFC95BC7EQ39222725-AE3A86A6-3E0E-4DAE-9343-1B9160DA054CQ39290492-2B0DA671-4984-4518-AD90-9F014B8A867DQ39515321-B0954AAA-4FE0-4118-A8F1-2EE75A3F5BE6Q39574224-6C39246E-5ABB-43E5-B044-39761A75DDEDQ42001195-E7BC91DB-54F8-4DB5-9D9A-1C937CCA73F9Q43778009-E410AB54-853C-47C2-BBE7-8EE4A18E0350Q46889712-BD5D4CE0-3774-4494-8EDE-E1ED63B9E012Q47103306-B2FC1E00-670D-43E1-B886-1933A3C10B23Q47169877-47721CCC-4FE8-4EC5-AC24-BB79FAB033DEQ54517081-4C0C7002-C078-4B52-B979-1AC95BF2864D
P2860
Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Changes in the expression of m ...... n hepatocarcinoma HepG2 cells.
@en
Changes in the expression of m ...... n hepatocarcinoma HepG2 cells.
@nl
type
label
Changes in the expression of m ...... n hepatocarcinoma HepG2 cells.
@en
Changes in the expression of m ...... n hepatocarcinoma HepG2 cells.
@nl
prefLabel
Changes in the expression of m ...... n hepatocarcinoma HepG2 cells.
@en
Changes in the expression of m ...... n hepatocarcinoma HepG2 cells.
@nl
P50
P1476
Changes in the expression of m ...... in hepatocarcinoma HepG2 cells
@en
P2093
Andrés García-Palomo
Javier Martín-Renedo
P304
P356
10.1111/J.1600-079X.2009.00719.X
P577
2009-10-10T00:00:00Z